首页> 外文期刊>International Journal of Ayurvedic Medicine >Clinical evaluation of shankhapani rasa in the management of kashtartava (dysmenorrhoea)
【24h】

Clinical evaluation of shankhapani rasa in the management of kashtartava (dysmenorrhoea)

机译:shankhapani rasa在卡什塔塔瓦(痛经)治疗中的临床评价

获取原文
           

摘要

Menstrual pain which is severe enough to limit normal activities is termed as Kashtartava (dysmenorrhoea). Dysmenorrhoea is the most common gynecological problem faced by women due to abnormal anatomical and functional aspect of uterus, pschycosomatic factors, release of prostaglandins, pelvic congestion etc. Shankhapani Rasa which is a Herbo-Mineral formulation posses all the contents having vatahara and gulmahara properties.The clinal Study was carried out to evaluate the efficacy of Shankhapani Rasa in patients suffering from Kashtartava by selecting 30 patients who attended the O.P.D. and I.P.D. of S.V.Ayurvedic Hospital Tirupathi during the period 2011-2012. Patients were given Shankhapani Rasa in a dose of 125mg capsules twice in a day for 1 month randomly and effect was evaluated on pre-test and post-test design.Statistically significant (p<0.01) results were seen in Subjective symptoms like pain during menstruation and duration of pain giving a conclusion that Shankhapani Rasa is effective in the management of Kashtartava.
机译:月经痛,其严重程度足以限制其正常活动,被称为卡什塔塔瓦(痛经)。痛经是妇女最常见的妇科问题,原因是子宫的解剖学和功能异常,pscocosomatic因子,前列腺素的释放,骨盆充血等。Shankhapani Rasa是一种草药-矿物配方,具有所有具有vatahara和gulmahara性质的成分。通过选择30名参加OPD的患者,进行了临床研究,以评估Shankhapani Rasa对喀什塔塔瓦邦患者的疗效和I.P.D. 2011年至2012年期间,Ayurvedic S.V.阿育吠陀医院。患者每月两次随机服用Shankhapani Rasa剂量为125mg的胶囊,持续1个月,并在试验前和试验后设计中评估效果。月经期间疼痛等主观症状的统计学意义(p <0.01)有统计学意义疼痛持续时间得出结论,Shankhapani Rasa可有效治疗Kashtartava。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号